Uncontrolled bleeding in surgical patients: The role of recombinant activated factor VIIa

Current Drug Targets

Volumn 10, Issue 8, 2009, Pages 744-770

  Phillips, L E ^a   Zatta, A J ^a   Schembri, N L ^a   Noone, A K ^a   Isbister, J ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; VON WILLEBRAND FACTOR; BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN;

ABDOMINAL SURGERY; ACUTE HEART INFARCTION; ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CANCER SURGERY; CAROTID ARTERY THROMBOSIS; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM THROMBOSIS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART TAMPONADE; HEMOSTASIS; HUMAN; KIDNEY TRANSPLANTATION; LIVER RESECTION; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG TRANSPLANTATION; MESENTERIC VEIN THROMBOSIS; NECROTIZING ENTEROCOLITIS; NEUROSURGERY; OBSTETRIC OPERATION; OFF LABEL DRUG USE; ORTHOPEDIC SURGERY; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PORTAL VEIN THROMBOSIS; REVIEW; SURGICAL PATIENT; THORAX SURGERY; THROMBECTOMY; THROMBOEMBOLISM; THROMBOGENICITY; THROMBOPHLEBITIS; THROMBOSIS; TRAUMATOLOGY; VASCULAR SURGERY; VEIN THROMBOSIS;

FACTOR VIIA; HEMORRHAGE; HUMANS; RECOMBINANT PROTEINS;

EID: 70350774267     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009788982469     Document Type: Review

References (242)

1. Hedner U, Ezban M. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis. Ann Rev Med 2008; 59: 29-41. (Pubitemid 351287922)
2. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245(5): 812-818
3. Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 2008; 106(3): 732-738 (Pubitemid 351301386)
4. Fries D, Innerhofer P, Reif C, Streif W, Klingler A, Schobersberger W, et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006; 102(2): 347-351 (Pubitemid 43152574)
5. Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J, Cameron P. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand haemostasis Register. Intern Med J 2008; 38(3): 156-165 (Pubitemid 351271402)
6. Zangrillo A, Mizzi A, Biondi-Zoccai G, Bignami E, Calabro MG, Pappalardo F, et al. Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2009; 23(1): 34-40.
7. Kapapa T, Konig K, Heissler HE, Schatzmann C, Tschan CA, Perl M, et al. The use of recombinant activated factor VII in neurosurgery. Surg Neurol 2009; 71(2): 172-179
8. von Heymann C, Jonas S, Spies C, Wernecke KD, Ziemer S, Janssen D, et al. Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data. Crit Care 2008; 12(1): R14. (Pubitemid 351359731)
9. O'Keeffe T, Refaai M, Tchorz K, Forestner JE, Sarode R. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008; 143(7): 686-690 (Pubitemid 352040242)
10. Ramsey G. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review. Best Pract Res Clin Haematol 2006; 19(1): 113-126 (Pubitemid 43123875)
11. Tanos M, Dunning J. Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery? Interact Cardiovasc Thorac Surg 2006; 5(4): 493-498
12. Scarpelini S, Rizoli S. Recombinant factor VIIa and the surgical patient. Curr Opin Crit Care 2006; 12(4): 351-356 (Pubitemid 44078149)
13. Tawfick WA, Tawfik S, Hynes N, Mahendran B, Sultan S. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII. Vascular 2006; 14(1): 32-37
14. Johansson PI. Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials. Vox Sang 2008; 95: 1-7.
15. Boffard KD, Riou B, Warren B, Choong PIT, Rizoli S, Rossaint R, et al. Recombinant Factor VIIa as adjunct therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 8-18. (Pubitemid 41271632)
16. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005; 95(5): 596-602. (Pubitemid 41600019)
17. Lodge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, et al. Efficacy and Safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005; 11(8): 973-979. (Pubitemid 41122456)
18. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol 2008; 21(5): 664-668
19. Spiess BD. Blood transfusion: the silent epidemic. Ann Thorac Surg 2001; 72(5): S1832-7.
20. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113(15): 3406-3417
21. Bartal C, Yitzhak A. The role of thromboelastometry and recombinant factor VIIa in trauma. Curr Opin Anaesthesiol 2009; Early release pre publication.
22. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354: 1879.
23. Cameron P, Phillips L, Balogh Z, Joseph A, Pearce A, Parr M, et al. The use of recombinant activated factor VII in trauma patients: Experience from the Australian and New Zealand haemostasis registry. Injury 2007; 38: 1030-1038 (Pubitemid 47277405)
24. Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, et al. Recombinant activated factor VII in cardiac surgery: Experience from the Australian and New Zealand Haemostasis Registry. Ann Thorac Surg 2008; 85: 836-844 (Pubitemid 351255532)
25. Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J, Cameron P. Recombinant Activated Factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register. Intern Med J 2008; 38: 156-165 (Pubitemid 351271402)
26. Abdullah F, Hunter C, Hargrove C, Arnold M, Stein J. Recombinant factor VIIa for treatment of massive liver fracture in a premature infant. J Pediatr Surg 2006; 41(10): 1764-1767 (Pubitemid 44441363)
27. Apostolidou I, Sweeney MF, Missov E, Joyce LD, John R, Prielipp RC. Acute Left atrial thrombus after recombinant factor viia administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia. Anesth Analg 2008; 106(2): 404-408 (Pubitemid 351156660)
28. Ballen J, Raabe M, Muirhead B. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? Can J Anaesth 2006; 53(4): 353-356
29. Barro C, Wrobleski I, Piolat C, Cartal M, Dyon J-F, Jacquier C, et al. Successful use of recombinant factor VIIa for severe surgical liver bleeding in a 5 month-old baby. Haemophilia 2004; 10: 183-185 (Pubitemid 38312647)
30. Bianchi A, Jackson D, Maitz P, Thanakrishnan G. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns. Thromb Haemost 2004; 91(1): 203-204 (Pubitemid 38111240)
31. Boehlen F, Morales MA, Fontana P, Ricou B, Irion O, de Moerloose P. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. BJOG 2004; 111: 284-287 (Pubitemid 38299598)
32. Bouwmeester FW, Jonkhoff AR, Verheijen RHM, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003; 101(6):1174-1176 (Pubitemid 36694340)
33. Brown JL, Varma S, Morgan-Hughes NJ, Rocco G. Thrombosis related to emergency factor VIIa treatment. Anaesthesia 2003; 58: 1245. (Pubitemid 37508563)
34. Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patients supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg 2002; 124: 852-854
35. Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis 2006; 17(3): 213-216
36. Cheng C, Ho A. Use of recombinant activated factor VII after axillofemoral bypass grafting. Anaesth Intens Care 2006; 34: 375-378 (Pubitemid 43971050)
37. Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 2002; 110: 169-171 (Pubitemid 34742658)
38. Conen A, Weisser M, Tsakiris D, Siegemund M. Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding. BMC Infect Dis 2007; 7(1): 34. (Pubitemid 46831063)
39. Courtois L, Becher P, Miot S, Maisonnette-Escot Y, Sautiere JL, Berthier F, et al. Life threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use. J Gynecol, Obstet Biol Reprod 2007; 36(1): 78-82.
40. Danilos J, Paluszkiewicz P, Przesmycki K, Kotarski J. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery. Obstet Gynecol 2003; 101(6): 1172-1173 (Pubitemid 36694339)
41. Dart BW, Cockerham WT, Torres C, Kipikasa JH, Maxwell RA. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma 2004; 57: 171-174 (Pubitemid 39079256)
42. Dunkley SM, Mackie F. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent. Hematology 2003; 8: 263-264 (Pubitemid 37121750)
43. El Kinge AR, Mahfouz RA, Shamseddine AI, Taher AT. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder. Blood Coagul Fibrinolysis 2007; 18(6): 577-579 (Pubitemid 47344308)
44. Faber P, Reid C, El-Shafei H, Falase B, DeAnda A, DMazer. Recombinant Factor VIIa in the Management of Postoperative Bleeding After Repair for Inadvertently Thrombolysed Acute Type A Aortic Dissection. J Cardiothorac Vasc Anesth 2006; 30(5): 736-741 (Pubitemid 44470835)
45. Flood V, Galderisi F, Lowas S, Kendrick A, Boshkov L. Hemorrhagic Disease of the Newborn Despite Vitamin K Prophylaxis at Birth. Pediatr Blood Cancer 2007; 50: 1075-1077
46. Flynn JD, Pajoumand M, Camp PC, Jr., Jahania MS, Ramaiah C, Akers WS. Recombinant Factor VIIa for Refractory Bleeding Following Orthotopic Heart Transplantation. Ann Pharmacother 2004; 38(10): 1639-1642 (Pubitemid 39297761)
47. Flynn J, Camp P, Jahania S, Ramaiah C, Akers W. Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII. . ASAIO J 2004; 50(5): 519-521 (Pubitemid 39237965)
48. Gerlach R, Marquardt G, Wissing H, Scharrer I, Raabe A, Seifert V. Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. J Neurosurg 2002; 96: 946-948 (Pubitemid 34415411)
49. Gielen-Wijffels SE, van Mook WN, van der Geest S, Ramsay G. Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation. Intens Care Med 2004; 30: 1232-1234 (Pubitemid 38833383)
50. Goldberg R, Drummond KJ. Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma. J Clin Neurosci 2008; 15(10): 1164-1166
51. Haan J, Scalea TM. A Jehovah's Witness with Complex Abdominal Trauma and Coagulopathy: Use of Factor VII and a Review of the Literature. Am Surg 2005; 71(5): 414-415 (Pubitemid 43073461)
52. Heilmann L, Wild C, Hojnacki B, Pollow K. Successful Treatment of Life-threatening Bleeding after Cesarean Section with Recombinant Activated Factor VII. Clin Appl Thromb Hemost 2006; 12(2): 227-229 (Pubitemid 44400867)
53. Heise D, and AB, Quintel M. Recombinant activated factor VII (Novo7®) in patients with ventricular assist devices: Case report and review of the current literature. J Cardiothorac Surg 2007; 2(47).
54. Hendriks HG, van der Maaten JM, de Wolf J, Waterbolk TW, Sloof MJ, van der Meer J. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001; 93(2): 287-289
55. Holcomb JB, Neville HL, Fischer CF, Hoots K. Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient. Curr Surg 2003; 60(4): 423-427 (Pubitemid 36827320)
56. Kamphuisen PW, van den Akker JM, Kaasjager KAH, Bloemen TIFM. Control of life-threatening pulmonary bleeding with activated recombinant factor VII. Am J Med 2002; 112: 332-333 (Pubitemid 34219456)
57. Karadimov D, Binev K, Nachkov Y, Platikanov V. Use of activated rebominant factor VII (NovoSeven) during neurosurgery. J Neurosurg Anesth 2003; 15(4): 330-332 (Pubitemid 37210920)
58. Kastrup M, von Heymann C, Hotz H, Konertz WF, Ziemer S, Kox WJ, et al. Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg 2002; 74(3): 910-912 (Pubitemid 35001829)
59. Khan Z, Soltani A, Rahmani P. Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation. J Anaesth 2007; 21: 258-260 (Pubitemid 46692019)
60. Kogan A, Berman M, Stein M, Vidne BA, Raanani E. Recombinant factor VIIa use in cardiac surgery - expanding the arsenal therapy for intractable bleeding? J Cardiovasc Surg 2004; 45(6): 569-571
61. Korte WC, Moor S. Near Fatal Hemorrhage in Traumatic Bilateral Leg Amputation with Coagulopathy, Acidosis, and Hyperthermia nad Salvage Therapy with Recombinant Factor VIIa. J Trauma 2007; 63(1): E1-E4. (Pubitemid 47057593)
62. Langer H, Strohmaier WL, Probst S. Treatment of a subcapsular renal bleeding after extracorporeal shockwave lithotripsy with recombinant, activated factor VII. Anaesthesist 2002; 51(11): 914-917 (Pubitemid 35430631)
63. Leibovitch L, Kenet G, Mazor K, Matok I, Vardi A, Barzilay Z, et al. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery. Pediatr Crit Care Med 2003; 4: 444-446
64. Lim Y, Loo C, Chia V, Fun W. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Int J Gynecol Obstet 2004; 87: 178-179 (Pubitemid 39446015)
65. Lucey MA, Myburgh JA. Recombinant Activated Factor VII for Exsanguinating Haemorrhage Post Bilateral Lung Transplantation for Extra-corporeal Lung Support-dependent Respiratory Failure. Anaesth Intensive Care 2003; 31(4): 465-469
66. Mahmoud A, Al-Ruzzeh S, McKeague H, Cross M. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery. Tex Heart Inst J 2007; 34: 485-488
67. Manning BJ, Hynes N, Courtney DF, Sultan ST. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. Eur J Vas Endovasc Surg 2005; 30: 525-527 (Pubitemid 41472423)
68. Marson F, Farnia A, Callegher L, Casagrande L, Surdu M, Sarpellon M. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report. Minerva Anestesiol 2006; 72(7-8): 675-682 (Pubitemid 44251573)
69. McIlroy DR, Silvers AJ. Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotonin. Anesth Analg 2004; 99: 27-30. (Pubitemid 38808158)
70. Mechsner S, Baessler K, Brunne B, Albrecht T, Hopp H, Dudenhausen JW. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta. Fert Steril 2008; 90(5): 2012.e1-e5.
71. Moeller MS. Indications for use of recombinant factor VIIa: A case study with implications for research. J Trauma Nurs 2006; 13(4): 190-192
72. Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 114: 174-176 (Pubitemid 32702652)
73. Naik V, Mazer C, Latter D, Teitel J, Hare G. Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass. Can J Anesth 2003; 50(6): 599-602. (Pubitemid 37038478)
74. Ng HJ, Koh LP, Lee LH. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin. Ann Hematol 2003; 82: 257-258
75. Noda M, Morozumi J, Mishima S, Sasaki H, Yukioka T, Ohta S. Visualization of efficacy of recombinant factor FVIIa in a pelvic fracture patient. J Trauma 2008; 64: E86-8.
76. O'Neill PA, Bluth M, Gloster ES, Wali D, Priovolos S, DiMaio TM, et al. Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma 2002; 52: 400-405 (Pubitemid 34183816)
77. Pang G, Donaldson A. Probable right atrial thrombus immediately after recombinant activated factor VII administration. Br J Anaesth 2007; 99(2): 221-225 (Pubitemid 47249394)
78. Pichon N, Bellec F, Sekkal S, Marsaud J, Laskar M, Francios B, et al. Fatal thrombotic events after infusion of recombinant activated factor VII after cardiac surgery. J Thorac Cardiovasc Surg 2008; 136(1): 220-221
79. Potapov E, Pasic M, Bauer M, Hetzer R. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg 2002; 74(6): 2182-2183 (Pubitemid 35440907)
80. Price G, Kaplan J, Skowronkski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient. Br J Anaesth 2004; 93(2): 298-300. (Pubitemid 39117408)
81. Raux M, Chiche L, Vanhille E, Riou B. Recombinant activated factor VII to control massive post operative bleeding after septic aortobifemoral grafting. Eur J Anaesthesiol 2005; 22: 805-807 (Pubitemid 41391661)
82. Romero-Castro R, Jimenez-Saenz M, Pellicer-Bautista F, Herrerias-Gutierrez JM. Refractory bleeding after endoscopic sphincterotomy: a new indication for recombinant factor VII therapy? Am J Gastroenterol 2004; 99: 2063-2065
83. Sanchez MP, Nebreda JB, Garcia VC. Recombinant activated factor VII prevents bleeding during a surgical procedure in a patient with uncontrollable rectal hemorrhage. Am J Gastroenterol 2002; 97(5): 1266-1267
84. Sander M, von Heymann C, Kox WJ, Spies CD, Turk I, Loening SA, et al. Recombinant factor VIIa for excessive bleeding after thrombectomy prior to kidney transplantation. Transplantation 2004; 77(12): 1912-1913 (Pubitemid 38822224)
85. Schuster R, Lee SJ, Rink D. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa. Am Surg 2003; 69(11): 1017-1018
86. Siegel LJ, Gerigk L, Tuettenberg J, Dempfle C-E, Scharf J, Fiedler F. Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion. Anesthesiology 2004; 100: 441-443 (Pubitemid 38133715)
87. Slappendel R, Huvers FC, Benraad B, Novakova I, van Hellemondt GG. Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia. Anaesthesiology 2002; 96(6): 1525-1527 (Pubitemid 34587229)
88. Sobieszczyk S, Breborowicz GH, Markwitz W, Mallinger S, Adamski D, Kruszynski Z. Effect of recombinant activated factor VII (rFVIIa; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy. Ginekol Pol 2002; 73(3): 230-233
89. Stratmann G, Russell I, Merrick S. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair. Ann Thorac Surg 2003; 76: 2094-2097 (Pubitemid 37510550)
90. Svartholm E, Annerhagen V, Länne T. Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa. Anesthesiology 2002; 96(6): 1528. (Pubitemid 34587230)
91. Szabo T, Syed A, Camporesi EM. Intraoperative recombinant activated factor VII for emergent epidural hematoma evacuation. Anesth Analg 2004; 99: 595-597 (Pubitemid 38970442)
92. Tobias J, Berkenbosch J. Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease. Clin pediatr 2002; 41(8): 613-616 (Pubitemid 35176445)
93. Tobias J, Berkenbosch J, Russo P. Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Ped 2003; 4(1): 12-16
94. Tobias JD, Berkenbosch JW, Muruve NA, Schmaltz RA. Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump. J Cardiothorac Vasc Anesth 2002; 16(5): 612-614
95. van der Schueren B, Hammer F, Verschuren F, Hantson P, Deneys V, Hermans C. Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma. Thromb Haemost 2005; 94(6): 1327-1328 (Pubitemid 41819634)
96. Verre M, Bossio F, Mammone A, Piccirillo M, Tancioni F, Varano M. use of recombinant activated factor VII in a case of severe postpartum haemorrhage. Minerva Anestesiol 2006; 58: 81-84
97. Verrijckt A, Proulx F, Morneau S, Vobecky S. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2004; 127(6): 1812-1813 (Pubitemid 38725466)
98. Vlachos K, Archontovasilis F, Papadima A, Maragiannis D, Aloizos S, Lagoudianakis E, et al. Successful use of recombinant activated factor VII for postoperative associated haemorrhage: a case report. Cases J 2008; 1(1): 361.
99. Vlot AJ, Ton E, Mackaay AJ, Kramer MH, Gaillard CA. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med 2000; 108: 421-422
100. Von Heymann C, Hotz H, Konertz W, Kox WJ, Spies C. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002; 16(5): 615-616 (Pubitemid 35155279)
101. Waddington DP, McAuley FT, Hanley JP, Summerfield GP. The use of recombinant factor VIIa in a Jehovah's Witness with autoimmune thrombocytopenia and post-splenectomy haemorrhage. Br J Haematol 2002; 119: 286-288
102. Wahed S, Karagounis AP, Niranjan G, Kanagasabay R. Successful Graft Patency after Factor VIIa Use for Bleeding in Coronary Artery Surgery: An Usual Complication of a Coronary Artery Bypass Surgery. J Cardiovasc Surg 2007; 22: 424-426
103. Wiesenack C, Arlt M, Liebold A, Schmid FX. Successful use of one dose of recombinant factor VIIa to control severe bleeding after emergency aortic arch replacement in deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2004; 128(6): 941-943 (Pubitemid 39575301)
104. Zietkiewicz M, Garlicki M, Domagala J, Wierzbicki K, Drwila R, Pfitzner R, et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 2002; 123(2): 384-385 (Pubitemid 34127142)
105. Zupancic Salek S, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M. Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome. Acta Haematol 2002; 108(3): 162-163 (Pubitemid 35316753)
106. Girisch M, Rauch R, Carbon R, Habash T, Hofbeck M. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa. Eur J Pediatr 2004; 163: 118-119 (Pubitemid 38223397)
107. El Accaoui R, Isma'eel H, Khalil PB, Taher A. A review of the off-label use of recombinant activated factor VII in a developing country tertiary care center. Blood Coagul Fibrinolysis 2006; 17(8): 647-650
108. Aggarwal A, Malkovska V, Catlett JP, Alcorn K. Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage. Thromb J 2004; 2: 9. (Pubitemid 41630791)
109. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005; 94(5): 592-595 (Pubitemid 40613803)
110. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002; 32(Supplement 1): 41-46 (Pubitemid 41296360)
111. Bartal C, Freedman J, Bowman K, Cusimano M. Coagulopathic Patients with Traumatic Intracranial Bleeding: Defining the Role of Recombinant Factor VIIa. J Trauma 2007; 63(4): 725-732 (Pubitemid 350287285)
112. Berkhof FF, Eikenboom JCJ. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis. Transfusion 2009; 49: 570-577
113. Bishop C, Renwick W, Hogan C, Haeusler M, Tuckfield A, Tatoulis J. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg 2006; 81(3): 875-879 (Pubitemid 43247653)
114. Biss TT, Hanley JP. Recombinant activated factor VII (rFVIIa/NovoSeven(R) ) in intractable haemorrhage: use of a clinical scoring system to predict outcome. Vox Sang 2006; 90: 45-52. (Pubitemid 43381270)
115. Bouma LS, Bolte AC, van Geijn HP. Use of recombinant activated factor VII in massive postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2008; 137(2): 172-177
116. Bowles KM, Callaghan CJ, Taylor AL, Harris RJ, Pettigrew GJ, Baglin TP, et al. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage. Br J Anaesth 2006; 97(4): 476-481 (Pubitemid 44419960)
117. Brady K, Easley R, Tobias J. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Pediatr Anesth 2006; 16(10): 1042-1046 (Pubitemid 44401171)
118. Brandsborg Sr, SÃ,rensen B, Poulsen LH, Ingerslev Jr. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients. Blood Coagul Fibrinolysis 2006; 17(4): 241-249
119. Brȩborowicz G, Sobieszczyk S, Szymankiewicz M. Efficacy of recombinant activated factor VII (rFVIIa, NovoSeven®) in prenatal medicine. Arch Perinat Med 2002; 8(2): 21-27
120. Buckmiller LM, Richter GT, Waner M, Suen JY. Use of recombinant factor VIIa during excision of vascular anomalies. Laryngoscope 2007; 117: 604-609 (Pubitemid 46559033)
121. Busani S, Semeraro G, Cantaroni C, Masetti M, Marietta M, Girardis M. Recombinant activated factor VII in critical bleeding after orthotopic liver transplantation. Transplant Proc 2008;40:1989-1990
122. Chino J, Paolini D, Tran A, Mathew P, Howdieshell TR. Recmobinant activated factor VII as an adjunct to packing for liver injury with hepatic venous disruption. Am J Surg 2005; 71(7): 595-597 (Pubitemid 43093201)
123. Ciacma A, De R, Malinowski B, Wlodarczyk B. Recombinant Activated Factor VII (rFVIIa) Effectively Controls Bleeding in Gynecologic Surgery: A Report on Four Cases. J Gynecol Surg 2005; 21(1): 13-20. (Pubitemid 40602745)
124. Das P, Carcao M, Hitzler J. Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. Pediatr Blood Cancer 2006; 47(2): 206-209 (Pubitemid 44025254)
125. DiDomenico RJ, Massaad MG, Kpodonu J, Navarro RA, Geha AS. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass. Chest 2005;127(5):1828-1835 (Pubitemid 46218814)
126. Dominguez TE, Mitchell M, Friess SH, Huh JW, Manno CS, Ravishankar C, et al. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2005; 6(3): 348-351 (Pubitemid 40724289)
127. Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003; 15: 184-188
128. Dutton RM, Maureen HM, D'Angelo M, O'Connor J, Hess J, Scalea T. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004; 57:709-719. (Pubitemid 39431190)
129. Egan JR, Lammi A, Schell DN, Gillis J, Nunn GR. Recombinant activated factor VII in paediatric cardiac surgery. Intens Care Med 2004; 30: 682-685 (Pubitemid 38530106)
130. Eikelbloom J, Bird R, Blythe D, Campbell J, Coyle L, Gan TE, et al. Recombinant activated factor VIIa for massive haemorrhage in nonhaemophilia patients: the Australian experience. In: ASBT; 2003: Transfusion Med; 2003. p. 110.
131. Felfernig M. Clinical experience with recombinant activated factor VII in a series of 45 trauma patients. J R Army Med Corps 2007; 153(1): 32-39
132. Felfernig M, Huepfl M. Experience of recombinant activated factor VII (NovoSeven®) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients. Clin Neurol Neurosurg 2008; 110: 227-232
133. Filan PM, Mills JF, Clarnette TD, Ekert H, Ekert P. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa. J Pediatr 2005; 147: 857-859 (Pubitemid 41774849)
134. Filsoufi F, Castillo J, Rahmanian P, Scurlock C, Fischer G, Adams D. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII. Ann Thorac Surg 2006; 82(5): 1779-1783 (Pubitemid 44584901)
135. Fontaine MJ, Lazarchick J, Taylor S, Annibale D. Use of recombinant factor VIIa in infants with severe coagulopathy. J Perinatol 2004; 24(5): 310-311 (Pubitemid 38684577)
136. Gandhi M, Pierce R, Zhang L, Moon M, Despotis G, Moazami N. Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg 2007; 2(32).
137. Geeraedts LMG, Kamphuisen PW, Kaasjager HAH, Verwiel JMM, Van Vugt AB, Frolke JPM. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma. Injury 2005; 36: 495-500. (Pubitemid 40332332)
138. Gowers C, Parr M. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy. Anaesth Intens Care 2005; 33: 196-200. (Pubitemid 40521019)
139. Grizelj R, Vukovic J, Filipovic-Grcic B, Saric D, Luetic T. Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. Blood Coagul Fibrinolysis 2006; 17(5): 413-415 (Pubitemid 43941585)
140. Grounds RM, Seebach C, Knothe C, Paluszkiewicz P, Smith TS, Kasal E, et al. Use of recombinant activated factor VII (NovoSeven) in trauma and surgery: analysis of outcomes reported to an international registry. J Intensive Care Med 2006; 21: 27-39.
141. Guyot E, Carillion A, Poli-Me M, Ferrand I, Chauvet P, Nguyen P, et al. Use of rFVIIa in two children presenting major bleeding not controlled by the usual treatments before emergent surgery. Pediatr Anesth 2008; 18: 1211-1281
142. Guzzetta N, Huch S, Fernandez J, Tosone S, Miller B. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. Pediatr Anesth 2009; 19: 364-370
143. Haas T, Innerhofer P, Kuhbacher G, Fries D. Successful reversal of deleterious coagulopathy by recombinant factor VIIa. Anesth Analg 2005; 100: 54-58 (Pubitemid 40013602)
144. Halkos ME, Levy JH, Chen E, Reddy VS, Lattouf OM, Guyton RA, et al. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery. Ann Thoracic Surg 2005; 79(4): 1303-1306 (Pubitemid 40431856)
145. Hall K, Forrest P, Sawyer C. The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration. Anaesth Intens Care 2007; 35: 494-497 (Pubitemid 47322311)
146. Hartmann M, Sucker C, Messing M. Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. J Neurosurg (1 Suppl Pediatrics) 2006; 104: 55-58
147. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 2007; 16: 40-49 (Pubitemid 44909444)
148. Heisel M, Nagib M, Madsen L, Alshiekh M, Bendel A. Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients. Pediatr Blood Cancer 2004; 43: 703-705 (Pubitemid 39411228)
149. Hendriks HG, Meijer K, de Wolf JTM, Klompmaker IJ, Porte RJ, de Kam PJ, et al. Reduced Trasfusion Requirements by Recombinant Factor VIIa in Orthotopic Liver Transplantation: A Pilot Study. Transplantation 2001; 71(3): 402-405 (Pubitemid 32175976)
150. Herbertson M, Kenet K. Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children. Haemophilia 2008; 14(4): 753-772
151. Hyllner M, Houltz E, Jeppsson A. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. Eur J Cardiothorac Surg 2005; 28: 254-258 (Pubitemid 41020693)
152. Jen H, Shew S. Recombinant activated factor VII use in critically ill infants with active hemorrhage. J Pediatr Surg 2008; 43(12): 2235-2238
153. Johansson, Eriksen K, Alsbjørn B. Rescue Treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: A Report of Four Cases. J Trauma 2006; 61: 1016-1018 (Pubitemid 44569452)
154. Kapapa T, König K, Heissler HE, Schatzmann C, Tschan CA, Perl M, et al. The use of recombinant activated factor VII in neurosurgery. Surg Neurol 2009; 71(2): 172-179
155. Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, et al. Comprehensive canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 2008; 118(4): 331-338
156. Kaw LL, Coimbra R, Potenza BM, Garfin SR, Hoyt DB. The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. Spine 2004; 29(12): 1384-1388
157. Khan AZ, Parry JM, Crowley WF, McAllen K, Davis AT, Bonnell BW, et al. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage. Am J Surg 2005; 189: 331-334 (Pubitemid 40431957)
158. Kogler VM, Solbodnjak Z, Samarzija M, Macan JS, Karadza V, Jakopovic M. Successful use of activated recombinant factor VII in life-threatining bleeding after therapic surgery. Swiss Med Wkly 2007; 137: 407-410 (Pubitemid 47121515)
159. Kolban M, Balachowska-Kosciolck I, Chmielnicki M. Recombinant coagulation factor VIIa-a novel haemostatic agent in scoliosis? Eur Spine J 2006; 15: 944-952
160. Kositchaiwat C, Chuansumrit A. Experiences with Recombinant Factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP). Thromb Haemost 2001; 86: 1125-1126 (Pubitemid 32975848)
161. Kulkarni RD, Alex. Guertin, Stephen. Fath, John. Atwal, Mandip. et al. Successful use of Activated recombinant fcator VII in traumatic liver injuries in children. J Trauma 2004; 56: 1348-1352
162. Laffan M, O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy D, Smith OP. Analysis and results of the recombinant factor VIIa extended-use registry. Blood Coagul Fibrinolysis 2003; 14(Suppl. 1): S35-S8. (Pubitemid 36951881)
163. Lamarche Y, Demers P, Poirier N, Robitaille D, Cartier R. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage. Can J Cardiol 2007; 23(10): 809-813 (Pubitemid 47468072)
164. Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 2003; 98(4): 737-740 (Pubitemid 36396775)
165. Loertzer H, Soukup J, Fornara P, Goldman A. Recombinant Factor VIIa Reduces Bleeding Risk in Patients on Platelet Aggregation Inhibitors Immediately prior to Renal Transplantation - A Retrospective Analysis. Urol Int 2007; 78: 135-139 (Pubitemid 46239133)
166. MacLaren R, Weber LA, Brake H, Gardner MA, Tanzi M. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes. Transfusion 2005; 45: 1434-1442 (Pubitemid 44194646)
167. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51: 431-439 (Pubitemid 33009625)
168. Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, et al. Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: A retrospective analysis of dosing, efficacy, and safety outcomes. J Cardiothorac Vasc Anesth 2009; 23(1): 28-33.
169. Mayo A, Misgavm M, Kluger Y, Geenberg R, Pauzner D, Klausner J, et al. Recombinant activated factor VII (NovoSeven (TM)): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding. Vox Sang 2004; 87: 34-40. (Pubitemid 39005745)
170. McCall P, Story DA, Karapillai D. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery. Can J Anaesth 2006; 53(9): 926-933 (Pubitemid 44696517)
171. McClelland S, Won EK, Lam CH. Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios. Neurocrit Care 2007; 7(2): 136-139
172. McMullin N, Kauvar D, Currier H, Baskin T, Pusateri A, Holcomb J. The clinical and laboratory response to recombinant factor VIIa in trauma and surgical patients with acquired coagulopathy. Curr Surg 2006; 63(4): 246-251 (Pubitemid 44028500)
173. Michalska-Krzanowska G, Sajdak R, Stasiak-Pikula E. Effects of recombinant factor VIIa in haemorrhagic complications of urological operations. Acta Haematol 2003; 109(3): 158-160 (Pubitemid 36506380)
174. Morenski JD, Tobias JD, Jimenez DF. Recombinant activated factor VII fir cerebral injury-induced coagulopathy in rediatric patients. Report of three cases and review of the literature. J Neurosurg 2003; 98(3): 611-616
175. Nussbaum ES, Janjua TM, Defillo A, Sinner P, Zelensky A. Perioperative Use of Recombinant Factor VII to Prevent Intraoperative Aneurysm Rupture in High Risk Patients: A Preliminary Safety Evaluation. Neurocrit Care 2009; 10(1): 55-60.
176. O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy DF, Laffan MA, Smith OP. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003; 43: 1711-1716 (Pubitemid 37518079)
177. Park P, Fewel ME, Garton HJ, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophiliac neurosurgical patients. Neurosurgery 2003; 53(1): 34-39 (Pubitemid 36801505)
178. Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C, et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases: [Le FVIIa corrige la coagulopathie d'une insuffisance hepatique fulminante, mais peut etre associe a la thrombose : presentation de quatre cas]. Can J Anesth 2005; 52(1): 26-29
179. Payne EM, Brett SJ, Laffan MA. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience. Blood Coagul Fibrinolysis 2006; 17(5): 397-402.
180. Perkins JG, Schreiber MA, Wade CE, Holcomb JB. Early Versus late recombinant factor VIIa in Combat trauma patients requiring massive transfusion. J Trauma 2007; 62(5):1095-1101
181. Pychynska-Pokorska M, Moll JJ, Krajewski W, Jarosik P. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004; 5: 246-250
182. Raivio P, Suojaranta-Ylinen R, Kuitunen A. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 2005; 80: 66-71. (Pubitemid 40840184)
183. Razon Y, Bernardo EE, Birk VE, Hanna JK, Dagan TO. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Pediatr Anesth 2005; 15(3): 235-240 (Pubitemid 40364750)
184. Segal S, Shemesh IY, Blumental R, Yoffe B, Laufer N, Ezra Y, et al. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynaecol Obstet 2003; 268: 266-267 (Pubitemid 37210326)
185. Segal S, Shemesh IY, Blumental R, Yoffe B, Laufer N, Mankuta D, et al. The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet et Gynecol Scand 2004; 83: 771-772 (Pubitemid 39062154)
186. Shamsi TS, Hossain N, Soomro N, Hasan JA, Noorani M, Kazi S, et al. Use of recombinant factor VIIa for massive postpartum haemorrhage: case series and review of literature. J Pak Med Assoc 2005; 55(11): 512-515
187. Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. Anesth Analg 2007; 104(4): 763-765 (Pubitemid 46548293)
188. Stein DM, Dutton RP, Hess JR, Scalea TM. Low-dose recombinant factor VIIa for trauma patients with coagulopathy. Injury 2008; 39: 1054-1061
189. Sutherland CS, Hill MD, Kaufmann AM, Silvaggio JA, Demchuk AM, Sutherland GR. Recombinant Factor VIIa plus Surgery for Intracerebral Hemorrhage. Can J Neurol Sci 2008; 35(5): 567-572
190. Tanaka KA, Waly AA, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven®). Anesthesiology 2003; 98: 1513-1515
191. Thomas GO, Dutton RP, Hemlock B, Stein DM, Hyder M, Shere-Wolfe R, et al. Thromboembolic complications associated with factor VIIa administration. J Trauma 2007; 62(3): 564-569 (Pubitemid 46568851)
192. Tobias JD. Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 2002; 96(6): 1522-1525
193. Tobias JD, Groeper K, Berkenbosch JW. Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 2003; 96(1): 12-16 (Pubitemid 36207377)
194. Udy A, Vaghela M, Lawton G, Sigston P. The use of recombinant activated Factor VII in the control of haemorrhage following blunt pelvic trauma. Anaesthesia 2005; 60(6): 613-616 (Pubitemid 40754141)
195. Uhrig L, Blanot S, Baugnon T, Orliaquet G, Carli PA, Meyer PG. use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Pediatr Crit Care Med 2007; 8(6): 576-579 (Pubitemid 350076465)
196. van de Garde EMW, Bras LJ, Heijmen RH, Knibbe CAJ, van Dongen EPA, Wiltink EHH, et al. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients. J Cardiothorac Vasc Anesth 2006; 20(4): 573-575
197. Vanek T, Straka Z, Hrabak J, Jared M, Brucek P, Votava J. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding. Jap Heart J 2004; 45(5): 855-860 (Pubitemid 40528892)
198. Veldman A, Neuhaeuser C, Akintuerk H, Thul J, Gehron J, Schranz D, et al. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Pediatr Anesth 2007; 17(12): 1176-1181 (Pubitemid 350059105)
199. Vick LR, Islam S. Recombinant factor VIIa as an adjunct in nonoperative management of solid organ injuries in children. J Pediatr Surg 2008; 43: 195-199
200. Vilstrup H, Markiewicz M, Biesma D, Brozovic VV, Laminoga N, Malik M, et al. Recombinant activated factor VII in an unselected series of cases with upper gastrointestinal bleeding. Thromb Res 2006; 118: 595-601. (Pubitemid 44414949)
201. von Heymann C, Redlich U, Jain R, Kastrup M, Schroeder T, Sander M, et al. Recombinant activated factor VII for refractory bleeding after cardiac surgery - a retrospective analysis of safety and efficacy. Crit Care Med 2005; 33(10): 2241-2246 (Pubitemid 41437477)
202. Walsham J, Fraser JF, Mullany D, Ziegenfus M, Chinthamuneedi M, Dunning J, et al. The use of recombinant activated factor Vll for refractory bleeding post complex cardiothoracic surgery. Anaesth Intensive Care 2006; 34(1): 13-20. (Pubitemid 43280143)
203. White B, McHale J, Ravi N, Reynolds J, Stephens R, Moriarty J, et al. Successful use of recombinant FVIIa (NovoSeven) in the management of intractable post-surgical intra-abdominal haemorrhage. Br J Haematol 1999; 107: 677-678
204. White MC, Pryn SJ, Monk CR. Thrombogenic Side-Effects of Recombinant Factor VIIa after use in Coronary Artery Bypass Surgery. Anaesth Intensive Care 2006; 34(5): 664-668
205. Wittenstein B, Ng C, Ravn H, Goldman A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med 2005; 6: 473-1176 (Pubitemid 40980831)
206. Yusim Y, Perel A, Berkenstadt H, Attia M, Knoller N, Sidi A. The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications. J Clin Anesth 2006; 18(7): 545-551 (Pubitemid 44780084)
207. Zaaroor M, Soustiel JF, Brenner B, Bar-Lavie Y, Martinowitz U, Levi L. Administration off label of recombinant factor VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy. Acta Neurochir 2008; 150(7): 663-668
208. Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lazarchick J, Crumbley Iii AJ, et al. Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery. Ann Thorac Surg 2008; 85(5): 1669-1677 (Pubitemid 351608196)
209. Clark AD, Gordon WC, Walker ID, Tait RC. 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang 2004; 86: 120-124
210. Meijera K, Hendriksc H, J de Wolfb, Klompmakerd I, Lismane T, Hagenaarsc A, et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 2003; 14(12): 169-174 (Pubitemid 36332479)
211. Rizoli S, Nascimento B, Osman F, Netto FS, Kiss A, Callum J, et al. Recombinant activated coagulation factor VII and bleeding trauma patients. J Trauma 2006; 61(6): 1419-1425 (Pubitemid 44973312)
212. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: A retrospective comparative study. Neurosurgery 2005;57(5): 832-836
213. Spinella P, Perkins J, McLaughlin D, Niles S, Grathwohl K, Beekley A, et al. The Effect of Recombinant activated Factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma 2008; 64(2): 286-294
214. Stein DM, Dutton RP, Kramer ME, Handley C, Scalea TM. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma 2008; 64: 620-628
215. Sugg RM, Gonzales NR, Matherne DE, Ribo M, Shaltoni HM, Baraniuk S, et al. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2006; 67(6): 1053-1055 (Pubitemid 44454603)
216. Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med 2004; 19(5): 270-273
217. Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 2005; 59: 150-154
218. Niles SD, Burkhart HM, Duffey DA, Buhrman K, Burzynski J, Holt DW. Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery. J Extra Corp Technol 2008; 40(4): 241-248
219. Romagnoli S, Bevilacqua S, Gelsomino S, Pradella S, Ghilli L, Rostagno C, et al. Small-dose recombinant activated factor VII (NovoSeven (R)) in cardiac surgery. Anesth Analg 2006; 102: 1320-1326
220. Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, et al. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven®): a propensity score analysis. Eur J Cardiothorac Surg 2008; 33(1): 64-71. (Pubitemid 350266356)
221. Karkouti K, Beattie WS, Wiljeysundera DN, Yau TM, McCluskey SA, Ghannam M, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case control analysis. Transfusion 2005; 45: 26-34.
222. Tritapepe L, De Santis V, Vitale D, Nencini C, Pellegrini F, Landoni G, et al. Recombinant activated factor VII for refractory bleeding after acute dissection surgery: a propensity score analysis. Crit Care Med 2007; 35(7): 1685-1690 (Pubitemid 46985870)
223. Karkouti K, Yau TM, Riazi S, Dattilo KM, Wasowizc M, Meineri M, et al. Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery. Can J Anesth 2006; 53(8): 802-809 (Pubitemid 44420066)
224. Stein D, Dutton R, Kramer M, Scalea T. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma 2009; 66: 63-75.
225. Isbister J, Dunkley S, Cameron P, Phillips L. The Australasian haemostasis register for clinical use of recombinant activated factor VII. ISBT Sci Series 2007; 2: 110-112
226. Rizoli S, Boffard KD, Riou B, Warren B, Iau P, Kluger Y, et al. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy subgroup analysis from two randomized trials. Crit Care 2006; 10(6): R178. (Pubitemid 46242736)
227. Kluger Y, Riou B, Rossaint R, Rizoli SB. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double blind clinical trial. Crit Care 2007; 11(4): R85. (Pubitemid 47335505)
228. Morris S, Ridley S, Munro V, Christensen MC. Cost effectiveness of recombinant activated factor VII for the control of bleeding in patients with severe blunt trauma injuries in the United Kingdom. Anaesthesia 2007; 62(1): 43-52. (Pubitemid 44869637)
229. Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, Gonzalez Abraldes J, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004; 127: 1123-1130 (Pubitemid 39345881)
230. Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology 2008; 47(5): 1604-1614 (Pubitemid 351702743)
231. Ekert H, Brizard C, Eyers R, Cochrane A, Henning R. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 2006; 17(5): 389-395
232. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth K-H, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003; 361: 201-205 (Pubitemid 36126219)
233. Jeffers L, Chalasani N, Balart L, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 2002; 123(1): 118-126 (Pubitemid 34747532)
234. Johansson P, Stensballe J, Rosenberg I, Hilslov T, Jorgensen L, Secher N. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion 2007; 47: 593-598 (Pubitemid 46449619)
235. Lodge JP, Jonas S, Oussoultzoglou E, Malago M, Jayr C, Cherqui D, et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 2005; 102: 269-275 (Pubitemid 40189073)
236. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-785
237. Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, et al. Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage. Stroke 2005; 36(1): 74-79 (Pubitemid 40054178)
238. Narayan RK, Maas AIR, Marshall LF, Servadei F, Skolnick BE, Tillinger MN, et al. Recombinant Factor Viia in Traumatic Intracerebral Hemorrhage: Results of A Dose-Escalation Clinical Trial. Neurosurgery 2008; 62(4): 776-788
239. Planinsic RM, Van der Meer J, Testa G, Grande L, Candela A, Porte RJ, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transplant 2005; 11(8): 895-900. (Pubitemid 41122446)
240. Raobaikady R, Redman J, Ball JAS, Maloney G, Grounds RM. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. Br J Anaesth 2005; 94(5): 586-591 (Pubitemid 40613802)
241. Sachs B, Delacy D, Green J, Graham RS, Ramsay J, Kreisler N, et al. Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. Spine 2007; 32(21): 2285-2293 (Pubitemid 47508833)
242. Shao YF, Yang JM, Chau GY, Sirivatanauksorn Y, Zhong SX, Erhardtsen E, et al. Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg 2006; 191: 245-249 (Pubitemid 43151275)